Lucentis

indicated assent.

Secondary information

Type: Proceeding contribution
Reference: 478 c1256
Session: 2007-08
Chamber / Committee: House of Commons chamber
Subjects: Finance Drugs Eyesight NHS Medical treatments National Institute for Health and Care Excellence Macular degeneration Visual impairment
Link: View this Proceeding contribution on www.publications.parliament.uk